Boceprevir and telaprevir: new treatments for chronic hepatitis C


    loading  Checking for direct PDF access through Ovid

Abstract

Boceprevir and telaprevir are new antiviral drugs indicated for the treatment of chronic hepatitis C genotype 1 infection. In our New products review, Steve Chaplin presents the clinical data relating to their efficacy and adverse effects and Professor Geoffrey Dusheiko discusses their place in treatment.

    loading  Loading Related Articles